Dr. Denise Aberle has been elected to the National Academy of Medicine, one of the highest honors in the field of medicine and health. It demonstrates exceptional professional achievement as well as a commitment to service.
Dr. Aberle is a professor of radiology and bioengineering, and vice chair for research in the department of radiological sciences at DGSOM. She was recognized for leading the American College of Radiology Imaging National Cancer Institute–sponsored National Lung Screening Trial, in which low-dose CT screening was shown to reduce lung cancer mortality by 20 % over chest radiographic screening.
“I’m honored to be elected into the National Academy of Medicine, particularly in light of those in the Geffen School of Medicine who have preceded me,” Aberle said. “Although the results of the National Lung Screening Trial have changed U.S. health policy, screening implementation is still in its infancy. I’m privileged to continue my research with some extraordinary colleagues on this campus as we tackle some of the remaining challenges of lung cancer early detection.”
Dr. Aberle represents the excellence that our medical school community strives for – exceptional clinical care informed by leading-edge research while skillfully training future physicians and scientists.
Dr. Aberle and Dr. Mangione, professor of public health at UCLA, were among 100 new members announced on October 21, 2019, during the academy’s annual meeting in Washington D.C. They join 26 other current and emeriti faculty of our medical school who are members of the National Academy of Medicine.
